The Valley Desk

NCT02601313 · Interventional trial

Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 1 and Cohort 2)

Overall registry status Completed

Phase 2

Conditions Relapsed/Refractory Mantle Cell Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov